Kynurenine is correlated with IL-1β in plasma of schizophrenia patients
Authors:
- 6 January 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 125 (5) , 869-873
Abstract
The etiology of schizophrenia is still unclear. It is well-known that pro-inflammatory cytokines are higher in schizophrenia patients since the first episode psychosis comparing to healthy controls. Inflammatory downstream cascades influence different cellular pathways, like the displacement of the tryptophan (TRP) metabolism to the production of kynurenine (KYN) instead of serotonin, which results in the generation of several neuro and immunoactive metabolites. The aim of this study was to determine TRP, KYN and IL-1β plasma levels in first-onset schizophrenia (n = 28) and healthy controls (n = 30). The plasmatic levels of TRP and KYN were decreased in schizophrenic patients (p = 0.004 and p = 0.002, respectively), but there was no difference in the ratio of KYN/TRP (p = 0.554) or either in IL-1β (p = 0.101). Positive correlation was observed between KYN and IL-1β only in the schizophrenia group (r = 0.461, p = 0.021). And, there was also positive correlation between KYN and Positive and Negative Symptoms Scale (PANSS) (r = 0.395, p = 0.037). There is no correlation between the other analytes and other parameters of PANSS. Although our results of KYN have been different than expected and there was no difference in the KYN/TRP ratio, we observed a positive correlation between IL-1β and KYN, corroborating findings that pro-inflammatory agents hold up the KYN pathway.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/10350-9, 2014/20913-3)
- Associação Beneficente Alzira Denise Hertzog da Silva
- Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBioN) (2014/50873-3)
This publication has 43 references indexed in Scilit:
- RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patientsSchizophrenia Research, 2013
- Markers of inflammation in the prefrontal cortex of individuals with schizophreniaMolecular Psychiatry, 2013
- The kynurenine system and immunoregulationJournal of Neural Transmission, 2011
- Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With SchizophreniaSchizophrenia Bulletin, 2010
- Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With SchizophreniaSchizophrenia Bulletin, 2010
- Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in SchizophreniaSchizophrenia Bulletin, 2010
- Activation of brain interleukin-1β in schizophreniaMolecular Psychiatry, 2009
- Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based studyThe Lancet, 2009
- Kynurenine pathway in psychosis: evidence of increased tryptophan degradationJournal of Psychopharmacology, 2008
- Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease ??? there is no schizoaffective disorderCurrent Opinion in Psychiatry, 2007